democratisation of data

R&D

Clinical trials for drug development are becoming increasingly complex, with numerous variables that must be identified and defined from the start.

News

Eli Lilly's oral GLP-1 agonist Foundayo has been approved for weight management and type 2 diabetes in the UK, its first European market.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.